A service of StreetInsider.com
Welcome

Most Popular

AAPL 110.26
GOOG 381.02
RIMM 63.87
MSFT 25.50
C 15.75

Recently Added

VNQ 49.83
WNS 8.84
WSM 13.63
IPHS 19.98
SNC 0.01

Gaining Speed

CUTR 10.55
NOBL 2.73
PPC 3.93
CDSDD 3.04
NEWCO 0.00
2.93 +0.00 (0.00%) GERN

Click Here to Receive Instant E-mail and RSS Alerts

Stock Details

Last Trade:2.93 Change:+0.00 (0.00%) Prev Close:2.93 Open: 2.83 Days Range:2.93 – 2.93 52 Week Range: 1.95 - 8.15 Volume:1088773 P/E: N/A
EPS:-0.74

Member Comments

No member comments available for GERN


Not logged in - Log in or Sign up to leave comments

View AllRecent Alerts 10/14/08

Recent Alert on 08/12/08 at 8:41am
Geron (GERN) and Exeter Life Sciences Merge Start Licensing and ViaGen to Form Combined Licensing and Operating Company for Animal Cloning Technologies

Geron Corporation (Nasdaq: GERN) and Exeter Life Sciences, Inc. announced the merger of Start Licensing, Inc., a joint venture between Geron and Exeter Life Sciences, and ViaGen, Inc., a subsidiary of Exeter Life Sciences. Start manages and... Read More

Recent Alert on 07/30/08 at 4:45pm
Geron (GERN) Reports Q2 Loss of $0.17, Tops Street by 3c

View AllRecent Press Releases

Press Release on 10/10/08 at 2:37pm
Mergent, Inc. Announces Quarterly Rebalancing of HealthShares(TM) Indexes

View AllRecent SEC Filings

No Recent SEC Filings Available

View AllRecent Blog Posts

Blog Posts on 10/08/08 at 5:20am
Obama stock: Stem cell research benefits Geron (GERN)
Blog Posts on 10/07/08 at 8:00pm
Obama stock: Stem cell research benefits Geron (GERN)
Blog Posts on 05/27/08 at 6:28am
10 Biotechs in Stem Cells that Could Profit Under the Democrats
Blog Posts on 04/09/08 at 2:41am
Russian Roulette Pays Off for Antigenics
Blog Posts on 09/17/07 at 8:35am
Geron (GERN): 'Mind-boggling' study boost stem cell research firm